BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 15699127)

  • 1. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling.
    Watanabe M; Watanabe S; Hara Y; Harada Y; Kubo M; Tanabe K; Toma H; Abe R
    J Immunol; 2005 Feb; 174(4):1989-96. PubMed ID: 15699127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory roles of IL-2 and IL-4 in H4/inducible costimulator expression on activated CD4+ T cells during Th cell development.
    Yagi J; Arimura Y; Dianzani U; Uede T; Okamoto T; Uchiyama T
    J Immunol; 2003 Jul; 171(2):783-94. PubMed ID: 12847246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.
    Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Paul WE; Sher A
    J Immunol; 2000 Mar; 164(6):3047-55. PubMed ID: 10706693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 costimulation accelerates IL-4 receptor sensitivity and IL-4-mediated Th2 differentiation.
    Kubo M; Yamashita M; Abe R; Tada T; Okumura K; Ransom JT; Nakayama T
    J Immunol; 1999 Sep; 163(5):2432-42. PubMed ID: 10452978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion.
    Zhu J; Guo L; Watson CJ; Hu-Li J; Paul WE
    J Immunol; 2001 Jun; 166(12):7276-81. PubMed ID: 11390477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6.
    Kusam S; Toney LM; Sato H; Dent AL
    J Immunol; 2003 Mar; 170(5):2435-41. PubMed ID: 12594267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
    McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
    J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An IL-4R alpha allelic variant, I50, acts as a gain-of-function variant relative to V50 for Stat6, but not Th2 differentiation.
    Stephenson L; Johns MH; Woodward E; Mora AL; Boothby M
    J Immunol; 2004 Oct; 173(7):4523-8. PubMed ID: 15383584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo.
    Nawijn MC; Dingjan GM; Ferreira R; Lambrecht BN; Karis A; Grosveld F; Savelkoul H; Hendriks RW
    J Immunol; 2001 Jul; 167(2):724-32. PubMed ID: 11441076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment.
    Yamane H; Zhu J; Paul WE
    J Exp Med; 2005 Sep; 202(6):793-804. PubMed ID: 16172258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4-induced GATA-3 expression is a time-restricted instruction switch for Th2 cell differentiation.
    Seki N; Miyazaki M; Suzuki W; Hayashi K; Arima K; Myburgh E; Izuhara K; Brombacher F; Kubo M
    J Immunol; 2004 May; 172(10):6158-66. PubMed ID: 15128803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in T(h) cells and regulates their responses.
    Arimura Y; Kato H; Dianzani U; Okamoto T; Kamekura S; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T; Yagi J
    Int Immunol; 2002 Jun; 14(6):555-66. PubMed ID: 12039907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New programming of IL-4 receptor signal transduction in activated T cells: Stat6 induction and Th2 differentiation mediated by IL-4Ralpha lacking cytoplasmic tyrosines.
    Mora AL; Stephenson LM; Enerson B; Youn J; Keegan AD; Boothby M
    J Immunol; 2003 Aug; 171(4):1891-900. PubMed ID: 12902491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.
    Parry RV; Rumbley CA; Vandenberghe LH; June CH; Riley JL
    J Immunol; 2003 Jul; 171(1):166-74. PubMed ID: 12816995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation.
    Yang Y; Ochando J; Yopp A; Bromberg JS; Ding Y
    J Immunol; 2005 Mar; 174(5):2720-9. PubMed ID: 15728480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation.
    Yamashita M; Kimura M; Kubo M; Shimizu C; Tada T; Perlmutter RM; Nakayama T
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):1024-9. PubMed ID: 9927687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional, naive CD4+ T cells provide an initial source of IL-4 during Th2 differentiation.
    Noben-Trauth N; Hu-Li J; Paul WE
    J Immunol; 2000 Oct; 165(7):3620-5. PubMed ID: 11034364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Th1 cell differentiation programming by CIITA deficiency.
    Patel DR; Kaplan MH; Chang CH
    J Immunol; 2004 Nov; 173(9):5501-8. PubMed ID: 15494498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex.
    Yamashita M; Katsumata M; Iwashima M; Kimura M; Shimizu C; Kamata T; Shin T; Seki N; Suzuki S; Taniguchi M; Nakayama T
    J Exp Med; 2000 Jun; 191(11):1869-79. PubMed ID: 10839803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.